Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Garcia-Cabeza, I; Diaz-Caneja, CM; Ovejero, M; de Portugal, E.

Adherence, insight and disability in paranoid schizophrenia

PSYCHIATRY RESEARCH. 2018; 270: 274-280 Nº de citas: 18 [doi:10.1016/j.psychres.2018.09.021]

Diaz-Caneja, CM; Moron-Nozaleda, MG; Vicente-Moreno, RP; Rodriguez-Toscano, E; Pina-Camacho, L; de la Serna, E; Sugranyes, G; Baeza, I; Romero, S; Sanchez-Gistau, V; Castro-Fornieles, J; Moreno, C; Moreno, D.

Temperament in child and adolescent offspring of patients with schizophrenia and bipolar disorder

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2018; 27(11): 1459-1471 Nº de citas: 12 [doi:10.1007/s00787-018-1135-y]

Amoretti, S; Cabrera, B; Torrent, C; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Parellada, M; Corripio, I; Vieta, E; de la Serna, E; Butjosa, A; Contreras, F; Sarro, S; Penades, R; Sanchez-Torres, AM; Cuesta, M; Bernardo, M; PEPsGrp.

Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

ACTA PSYCHIATRICA SCANDINAVICA. 2018; 138(5): 441-455 Nº de citas: 70 [doi:10.1111/acps.12949]

Szerman, N; Peris, L.

Precision Psychiatry and Dual Disorders

Journal of Dual Diagnosis. 2018; 14(4): 237-246 Nº de citas: 29 [doi:10.1080/15504263.2018.1512727]

Ballesteros, A; Sanchez-Torres, AM; Lopez-Ilundain, JM; Cabrera, B; Lobo, A; Gonzalez-Pinto, AM; Diaz-Caneja, C; Corripio, I; Vieta, E; la Serna, E; Bobes, J; Usall, J; Contreras, F; Lorente-Omenaca, R; Mezquida, G; Bernardo, M; Cuesta, MJ; PEPs Grp.

Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

PSYCHOLOGICAL MEDICINE. 2018; 48(13): 2247-2256 Nº de citas: 53 [doi:10.1017/S0033291717003774]

Kahn, RS; van Rossum, IW; Leucht, S; McGuire, P; Lewis, SW; Leboyer, M; Arango, C; Dazzan, P; Drake, R; Heres, S; Diaz-Caneja, CM; Rujescu, D; Weiser, M; Galderisi, S; Glenthoj, B; Eijkemans, MJC; Fleischhacker, WW; Kapur, S; Sommer, IE; OPTIMISE Study Grp.

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

Lancet Psychiatry. 2018; 5(10): 797-807 Nº de citas: 158 [doi:10.1016/S2215-0366(18)30252-9]

Fiksinski, AM; Schneider, M; Murphy, CM; Armando, M; Vicari, S; Canyelles, JM; Gothelf, D; Eliez, S; Breetvelt, EJ; Arango, C; Vorstman, JAS.

Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome

AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 2018; 176(10): 2182-2191 Nº de citas: 47 [doi:10.1002/ajmg.a.40387]

Torrent, C; Reinares, M; Martinez-Aran, A; Cabrera, B; Amoretti, S; Corripio, I; Contreras, F; Sarro, S; Gonzalez-Pinto, A; Lobo, A; Cuesta, MJ; Sanchez-Torres, A; Berge, D; Castro-Fornieles, J; Moreno, C; Bernardo, M; Vieta, E; PEPS Grp.

Affective versus non-affective first episode psychoses: A longitudinal study

JOURNAL OF AFFECTIVE DISORDERS. 2018; 238: 297-304 Nº de citas: 34 [doi:10.1016/j.jad.2018.06.005]

Sanchez-Torres, AM; Moreno-Izco, L; Lorente-Omenaca, R; Cabrera, B; Lobo, A; Gonzalez-Pinto, AM; Merchan-Naranjo, J; Corripio, I; Vieta, E; de la Serna, E; Butjosa, A; Contreras, F; Sarro, S; Mezquida, G; Ribeiro, M; Bernardo, M; Cuesta, MJ; PEPs Grp.

Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2018; 268(7): 699-711 Nº de citas: 30 [doi:10.1007/s00406-017-0857-z]

Baeza, I; de la Serna, E; Calvo-Escalona, R; Merchan-Naranjo, J; Rodriguez-Latorre, P; Martinez-Cantarero, MC; Andres, P; Alda, JA; Munoz-Samons, D; Ilzarbe, D; Arango, C; Castro-Fornieles, J.

One-Year Prospective Study of Liver Function Tests in Children and Adolescents on Second-Generation Antipsychotics: Is There a Link with Metabolic Syndrome?

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. 2018; 28(7): 463-473 Nº de citas: 4 [doi:10.1089/cap.2017.0117]

Sanchez-Gutierrez, T; Garcia-Portilla, MP; Parellada, M; Bobes, J; Calvo, A; Moreno-Izco, L; Gonzalez-Pinto, A; Lobo, A; de la Serna, E; Cabrera, B; Torrent, C; Roldan, L; Sanjuan, J; Ibanez, A; Sanchez-Torres, AM; Corripio, I; Bernardo, M; Cuesta, MJ; Vieta, E; Martinez-Aran, A; Castro-Fornieles, J; Baeza, I; Bioque, M; Mezquida, G; Lopez-Ilundain, JM; Alonso, A; Rabela, M; Lopez, P; Zorrilla, I; Arbej, J; Rivero, G; Aguilar, EJ; Mane, A; Berge, D; Contreras, F; Albacete, A; Garcia-Alvarez, L; Al-Halabi, S; Gutierrez, M; Segarra, R; Morales-Munoz, I; Rodriguez-Jimenez, R; Butjosa, A; Usall, J; Sarro, S; Landin-Romero, R; Ruiz, JS; Balanza, V; PEPs Grp.

Smoking does not impact social and non-social cognition in patients with first episode psychosis

SCHIZOPHRENIA RESEARCH. 2018; 199: 64-74 Nº de citas: 14 [doi:10.1016/j.schres.2018.03.025]

Galderisi, S; Mucci, A; Buchanan, RW; Arango, C.

Negative symptoms of schizophrenia: new developments and unanswered research questions

Lancet Psychiatry. 2018; 5(8): 664-677 Nº de citas: 428 [doi:10.1016/S2215-0366(18)30050-6]

Csillag, C; Nordentoft, M; Mizuno, M; McDaid, D; Arango, C; Smith, J; Lora, A; Verma, S; Di Fiandra, T; Jones, PB.

Early intervention in psychosis: From clinical intervention to health system implementation

Early Intervention in Psychiatry. 2018; 12(4): 757-764 Nº de citas: 60 [doi:10.1111/eip.12514]

Sanchez-Moreno, J; Bonnin, CM; Gonzalez-Pinto, A; Amann, BL; Sole, B; Balanza-Martinez, V; Arango, C; Jimenez, E; Tabares-Seisdedos, R; Garcia-Portilla, MP; Ibáñez A; Crespo, JM; Ayuso-Mateos, JL; Martinez-Aran, A; Torrent, C; Vieta, E; CIBERSAM Functional Remediation Group.

Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

ACTA PSYCHIATRICA SCANDINAVICA. 2018; 138(2): 145-154 Nº de citas: 65 [doi:10.1111/acps.12894]

Baltasar-Tello, I; Miguelez-Fernandez, C; Penuelas-Calvo, I; Carballo, JJ.

Ecological Momentary Assessment and Mood Disorders in Children and Adolescents: a Systematic Review

Current Psychiatry Reports. 2018; 20(8): 66-66 Nº de citas: 28 [doi:10.1007/s11920-018-0913-z]

Soler, J; Fananas, L; Parellada, M; Krebs, MO; Rouleau, GA; Fatjo-Vilas, M.

Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review

JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2018; 43(4): 223-244 Nº de citas: 43 [doi:10.1503/jpn.170066]

Fernandez, A; Al-Timemy, AH; Ferre, F; Rubio, G; Escudero, J.

Complexity analysis of spontaneous brain activity in mood disorders: A magnetoencephalography study of bipolar disorder and major depression

COMPREHENSIVE PSYCHIATRY. 2018; 84: 112-117 Nº de citas: 12 [doi:10.1016/j.comppsych.2018.03.015]

Marrodan, IA; Perez, BSB; Acosta, MN; Vizcaino, EJV; Alvarez, MBC; Faci, TV.

Limits on the use of the MMSE for assessment of capacity to consent for treatment

EUROPEAN JOURNAL OF PSYCHIATRY. 2018; 32(3): 153-157 Nº de citas: 6 [doi:10.1016/j.ejpsy.2018.02.003]